CME Enterprise Value vs Net Income Analysis

CME Stock

USD 206.23 3.27 1.56%

CME financial indicator trend analysis is way more than just evaluating CME Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CME Group is a good investment. Please check the relationship between CME Enterprise Value and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Enterprise Value vs Net Income

Enterprise Value vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CME Group Enterprise Value account and Net Income. At this time, the significance of the direction appears to have strong relationship.

The correlation between CME's Enterprise Value and Net Income is 0.74. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Net Income in the same time period over historical financial statements of CME Group, assuming nothing else is changed. The correlation between historical values of CME's Enterprise Value and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of CME Group are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Enterprise Value i.e., CME's Enterprise Value and Net Income go up and down completely randomly.

Correlation Coefficient

0.74

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Enterprise Value

Enterprise Value (or EV) is usually referred to as CME theoretical takeover price. In the event of an acquisition, an acquirer would have to take on CME Group debt, but would also pocket its cash. Enterprise Value is more accurate representation of CME value than its market capitalization because it takes into account all of CME Group existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in CME Group financial statement analysis. It represents the amount of money remaining after all of CME Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	3.9B	4.3B	4.5B	2.5B
Total Revenue	4.7B	5.0B	5.6B	3.0B

Gross Profit Total Revenue

CME fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.58	0.99	0.99	0.63	-0.06	0.15	0.08	0.58	0.58	0.8	0.55	-0.24	-0.24	0.6	0.02	0.54	0.63	0.55	0.34	-0.29	0.63	1.0	0.35	0.99	0.52
Short Long Term Debt Total	0.58		0.49	0.49	0.9	0.26	0.51	0.71	0.87	0.79	0.56	0.89	0.02	0.05	0.95	0.03	0.44	0.7	0.81	0.76	-0.11	0.89	0.52	0.32	0.49	0.76
Other Current Liab	0.99	0.49		1.0	0.52	-0.12	0.05	-0.01	0.48	0.52	0.75	0.44	-0.28	-0.28	0.5	-0.03	0.51	0.55	0.43	0.21	-0.28	0.52	1.0	0.29	1.0	0.44
Total Current Liabilities	0.99	0.49	1.0		0.52	-0.12	0.04	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.03	0.5	0.55	0.43	0.21	-0.27	0.52	1.0	0.29	1.0	0.44
Total Stockholder Equity	0.63	0.9	0.52	0.52		0.26	0.64	0.5	0.94	0.61	0.6	0.99	0.13	0.08	0.9	0.22	0.33	0.68	0.97	0.89	0.0	1.0	0.56	0.29	0.52	0.78
Other Liab	-0.06	0.26	-0.12	-0.12	0.26		0.33	-0.04	0.19	-0.04	0.35	0.3	0.23	0.88	0.12	0.28	-0.01	0.13	0.32	0.39	0.04	0.26	-0.1	0.12	-0.12	0.15
Property Plant And Equipment Net	0.15	0.51	0.05	0.04	0.64	0.33		0.34	0.63	0.18	0.3	0.67	0.43	0.33	0.47	0.65	0.27	0.22	0.69	0.72	-0.19	0.63	0.08	0.59	0.05	0.24
Net Debt	0.08	0.71	-0.01	-0.01	0.5	-0.04	0.34		0.58	0.62	-0.09	0.52	0.19	-0.07	0.72	0.0	0.2	0.28	0.4	0.47	0.07	0.47	0.02	0.12	-0.01	0.31
Retained Earnings	0.58	0.87	0.48	0.49	0.94	0.19	0.63	0.58		0.61	0.47	0.91	0.18	0.1	0.86	0.29	0.26	0.52	0.86	0.75	0.07	0.9	0.52	0.25	0.49	0.62
Accounts Payable	0.58	0.79	0.52	0.53	0.61	-0.04	0.18	0.62	0.61		0.41	0.57	-0.49	-0.21	0.8	-0.05	0.45	0.48	0.46	0.4	-0.17	0.6	0.55	0.23	0.53	0.5
Cash	0.8	0.56	0.75	0.75	0.6	0.35	0.3	-0.09	0.47	0.41		0.56	-0.2	0.06	0.51	0.05	0.69	0.77	0.62	0.45	-0.53	0.62	0.77	0.6	0.75	0.58
Non Current Assets Total	0.55	0.89	0.44	0.44	0.99	0.3	0.67	0.52	0.91	0.57	0.56		0.17	0.12	0.89	0.23	0.3	0.68	0.98	0.95	0.03	0.99	0.48	0.28	0.44	0.78
Non Currrent Assets Other	-0.24	0.02	-0.28	-0.3	0.13	0.23	0.43	0.19	0.18	-0.49	-0.2	0.17		0.35	-0.06	0.4	-0.17	-0.15	0.19	0.26	0.15	0.1	-0.28	0.07	-0.3	-0.12
Other Assets	-0.24	0.05	-0.28	-0.27	0.08	0.88	0.33	-0.07	0.1	-0.21	0.06	0.12	0.35		-0.11	0.31	-0.29	-0.15	0.12	0.22	0.23	0.06	-0.26	-0.05	-0.27	-0.06
Long Term Debt	0.6	0.95	0.5	0.51	0.9	0.12	0.47	0.72	0.86	0.8	0.51	0.89	-0.06	-0.11		0.06	0.49	0.7	0.82	0.77	-0.13	0.89	0.54	0.34	0.51	0.72
Cash And Short Term Investments	0.02	0.03	-0.03	-0.03	0.22	0.28	0.65	0.0	0.29	-0.05	0.05	0.23	0.4	0.31	0.06		0.05	-0.36	0.26	0.25	-0.06	0.2	-0.01	0.35	-0.02	-0.38
Net Receivables	0.54	0.44	0.51	0.5	0.33	-0.01	0.27	0.2	0.26	0.45	0.69	0.3	-0.17	-0.29	0.49	0.05		0.61	0.33	0.21	-0.91	0.34	0.51	0.88	0.5	0.29
Common Stock Total Equity	0.63	0.7	0.55	0.55	0.68	0.13	0.22	0.28	0.52	0.48	0.77	0.68	-0.15	-0.15	0.7	-0.36	0.61		0.71	0.62	-0.36	0.71	0.58	0.42	0.55	0.87
Common Stock Shares Outstanding	0.55	0.81	0.43	0.43	0.97	0.32	0.69	0.4	0.86	0.46	0.62	0.98	0.19	0.12	0.82	0.26	0.33	0.71		0.95	-0.03	0.98	0.48	0.34	0.44	0.77
Non Current Liabilities Total	0.34	0.76	0.21	0.21	0.89	0.39	0.72	0.47	0.75	0.4	0.45	0.95	0.26	0.22	0.77	0.25	0.21	0.62	0.95		0.07	0.91	0.26	0.27	0.22	0.72
Other Current Assets	-0.29	-0.11	-0.28	-0.27	0.0	0.04	-0.19	0.07	0.07	-0.17	-0.53	0.03	0.15	0.23	-0.13	-0.06	-0.91	-0.36	-0.03	0.07		-0.02	-0.28	-0.89	-0.28	-0.03
Other Stockholder Equity	0.63	0.89	0.52	0.52	1.0	0.26	0.63	0.47	0.9	0.6	0.62	0.99	0.1	0.06	0.89	0.2	0.34	0.71	0.98	0.91	-0.02		0.56	0.3	0.53	0.81
Total Liab	1.0	0.52	1.0	1.0	0.56	-0.1	0.08	0.02	0.52	0.55	0.77	0.48	-0.28	-0.26	0.54	-0.01	0.51	0.58	0.48	0.26	-0.28	0.56		0.31	1.0	0.47
Property Plant And Equipment Gross	0.35	0.32	0.29	0.29	0.29	0.12	0.59	0.12	0.25	0.23	0.6	0.28	0.07	-0.05	0.34	0.35	0.88	0.42	0.34	0.27	-0.89	0.3	0.31		0.29	0.1
Total Current Assets	0.99	0.49	1.0	1.0	0.52	-0.12	0.05	-0.01	0.49	0.53	0.75	0.44	-0.3	-0.27	0.51	-0.02	0.5	0.55	0.44	0.22	-0.28	0.53	1.0	0.29		0.44
Common Stock	0.52	0.76	0.44	0.44	0.78	0.15	0.24	0.31	0.62	0.5	0.58	0.78	-0.12	-0.06	0.72	-0.38	0.29	0.87	0.77	0.72	-0.03	0.81	0.47	0.1	0.44

Click cells to compare fundamentals

CME Account Relationship Matchups

CME fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Short Long Term Debt Total	3.7B	3.4B	3.4B	3.4B	3.9B	2.4B
Other Current Liab	38.5B	88.1B	159.6B	132.2B	93.3B	98.0B
Total Current Liabilities	38.5B	88.2B	160.4B	137.7B	93.4B	98.1B
Total Stockholder Equity	26.1B	26.3B	27.4B	26.9B	26.7B	17.6B
Other Liab	6.2B	6.7B	6.3B	5.7B	6.6B	6.2B
Property Plant And Equipment Net	544M	579.2M	505.3M	455.5M	681.5M	483.4M
Net Debt	2.2B	1.8B	610.2M	718.3M	966.7M	843.5M
Retained Earnings	5.0B	5.0B	5.2B	4.7B	4.5B	3.0B
Accounts Payable	61.9M	69.3M	48.8M	121.4M	90.6M	51.7M
Cash	1.6B	1.6B	2.8B	2.7B	2.9B	3.1B
Non Current Assets Total	35.6B	35.4B	35.0B	35.1B	34.8B	24.0B
Non Currrent Assets Other	2.1B	2.0B	3.3B	(3.1B)	514.1M	1.0B
Other Assets	545.9M	7.3B	3.3B	574M	134.4M	127.7M
Long Term Debt	3.7B	3.4B	2.7B	3.4B	3.4B	2.5B
Cash And Short Term Investments	1.6B	1.7B	2.9B	2.8B	3.0B	2.7B
Net Receivables	491.8M	461.3M	434.5M	483.2M	1.3B	1.3B
Common Stock Shares Outstanding	358.2M	358.5M	358.9M	359.2M	359.5M	311.9M
Liabilities And Stockholders Equity	75.2B	124.7B	196.8B	174.2B	129.8B	136.3B
Non Current Liabilities Total	10.5B	10.1B	9.0B	9.6B	9.6B	7.4B
Other Current Assets	360.1M	302M	423M	524.9M	(4.3B)	(4.1B)
Other Stockholder Equity	21.1B	21.2B	22.2B	22.3B	22.3B	14.5B
Total Liab	49.1B	98.3B	169.4B	147.3B	103.1B	108.3B
Property Plant And Equipment Gross	544M	579.2M	505.3M	455.5M	1.3B	1.4B
Total Current Assets	39.6B	89.3B	161.8B	139.1B	94.9B	99.6B
Accumulated Other Comprehensive Income	3.4M	134.9M	53.5M	(133.3M)	(55.6M)	(52.8M)
Property Plant Equipment	544M	579.2M	505.3M	837.6M	963.2M	490.1M
Short Term Investments	83.2M	100.9M	115M	96M	111.7M	106.1M
Inventory	37.1B	86.8B	158.0B	135.3B	155.5B	163.3B
Short Term Debt	49.7M	52.2M	749.4M	16M	55.1M	52.3M
Intangible Assets	22.3B	22.0B	20.7B	20.4B	20.2B	18.4B
Good Will	10.7B	10.8B	10.5B	10.5B	10.5B	8.9B
Retained Earnings Total Equity	4.9B	5.0B	5.0B	5.2B	5.9B	3.7B
Deferred Long Term Liab	5.7B	5.6B	5.6B	5.4B	6.2B	4.7B
Net Tangible Assets	(6.9B)	(6.5B)	(3.8B)	(4.0B)	(4.7B)	(4.9B)
Long Term Debt Total	3.8B	3.7B	3.4B	2.7B	3.1B	2.9B

Pair Trading with CME

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.

Moving together with CME Stock

0.87

ICE

Intercontinental Exchange Financial Report 2nd of May 2024

Pair Corr

Moving against CME Stock

0.73	DHIL	Diamond Hill Investment	Pair Corr
0.68	FG	FG Annuities Life Financial Report 1st of May 2024	Pair Corr
0.62	BY	Byline Bancorp Report 25th of April 2024	Pair Corr
0.58	SPGI	SP Global Financial Report 25th of April 2024	Pair Corr
0.51	VALU	Value Line	Pair Corr

The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.

The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:

How To Invest In CME

Details

Is CME Stock a good investment?

Details

What is CME's Net Worth?

Details

Largest Financial Exchanges & Data Companies

View

Largest Financial Data & Stock Exchanges Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Transaction History View history of all your transactions and understand their impact on performance
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Global Correlations Find global opportunities by holding instruments from different markets
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device

Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.276

Dividend Share

4.4

Earnings Share

8.87

Revenue Per Share

15.512

Quarterly Revenue Growth

0.192

The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CME Enterprise Value vs Net Income Analysis

Enterprise Value vs Net Income

Enterprise Value vs Net Income Correlation Analysis

Correlation Coefficient

Enterprise Value

Net Income

CME fundamental ratios Correlations

CME Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CME fundamental ratios Accounts

Pair Trading with CME

Moving together with CME Stock

Moving against CME Stock

Complementary Tools for CME Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Current Liabilities

Other Current Assets	- 0.91	Net Receivables
Property Plant And Equipment Gross	- 0.89	Other Current Assets
Other Current Assets	- 0.53	Cash
Non Currrent Assets Other	- 0.49	Accounts Payable
Common Stock	- 0.38	Cash And Short Term Investments
Other Current Assets	- 0.36	Common Stock Total Equity